Resona Asset Management Co. Ltd. cut its position in Abbott Laboratories (NYSE:ABT – Free Report) by 1.6% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 557,184 shares of the healthcare product maker’s stock after selling 9,081 shares during the period. Resona […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.